Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated statements of comprehensive income (loss)

v3.22.1
Consolidated statements of comprehensive income (loss) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]      
Revenue $ 137,668 $ 93,486 $ 70,590
Cost of revenue 31,752 21,417 20,512
Gross profit 105,916 72,069 50,078
Operating expenses:      
Research and development 44,378 22,086 16,212
Sales and marketing 93,844 53,690 38,934
General and administrative 33,801 15,967 11,044
Total operating expenses 172,023 91,743 66,190
Loss from operations (66,107) (19,674) (16,112)
Finance expenses, net (1,891) (1,682) (1,137)
Loss before income taxes (67,998) (21,356) (17,249)
Provision for income taxes 981 640 458
Net loss (68,979) (21,996) (17,707)
Deemed dividend to ordinary and preferred shareholders 0 (825) 0
Net loss $ (68,979) $ (22,821) $ (17,707)
Net loss per share attributable to ordinary shareholders, basic (in USD per share) $ (1.30) $ (1.58) $ (1.32)
Net loss per share attributable to ordinary shareholders, diluted (in USD per share) $ (1.30) $ (1.58) $ (1.32)
Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, basic (in shares) 53,201,603 14,442,172 13,427,020
Weighted-average shares used in computing net loss per share attributable to ordinary shareholders, diliuted (in shares) 53,201,603 14,442,172 13,427,020
Other comprehensive income (loss), net of tax      
Change in unrealized gain (loss) on cashflow hedges $ 84 $ (73) $ 496
Total other comprehensive income (loss), net of tax 84 (73) 496
Total comprehensive loss $ (68,895) $ (22,069) $ (17,211)